# Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers

> **NCT02894957** · PHASE4 · UNKNOWN · sponsor: **Shaare Zedek Medical Center** · enrollment: 250 (estimated)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT02894957
- **Lead sponsor:** Shaare Zedek Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-10
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02894957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02894957, "Varenicline for "Gradual" vs. "Abrupt" Smoking Cessation in Low-motivated COPD Smokers". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02894957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*